Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: A single institution's experience over 14 years

Gynecologic and Obstetric Investigation

Volumn 71, Issue 1, 2011, Pages 19-23

  Kim, Woo Young ^a   Chang, Suk Joon ^a   Chang, Ki Hong ^a   Yoo, Seung Chul ^a   Chun, Mison ^a   Ryu, Hee Sug ^a  

^a Ajou University Medical Center   (South Korea)

Author keywords

IB2 cervical cancer; Ovarian preservation; Surgical approach; Treatment options

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; OVARY FUNCTION; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARY; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78651432255     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320722     Document Type: Article

References (15)

1. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-1153.
2. Michalas S, Rodolakis A, Voulgaris Z, Vlachos G, Giannakoulis N, Diakomanolis E: Management of early-stage cervical carcinoma by modified (type II) radical hysterectomy. Gynecol Oncol 2002; 85: 415-422.
3. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-540.
4. Hopkins MP, Morley GW: Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 1991; 68: 272-277.
5. Russell AH, Shingleton HM, Jones WB, Stewart AK, Fremgen A, Winchester DP, et al: Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998; 40: 605-613.
6. Hacker NF: Clinical and operative staging of cervical cancer. Baillieres Clin Obstet Gynaecol 1988; 2: 747-759.
7. Abitbol MM, Davenport JH: Sexual dysfunction after therapy for cervical carcinoma. Am J Obstet Gynecol 1974; 119: 181-189.
8. Finan MA, DeCesare S, Fiorica JV, et al: Radical hysterectomy for stage IB1 versus IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol 1996; 62: 139-147.
9. Benedet J, Maisonneuve P, et al: Carcinoma of the cervix uteri: annual report on the results of treatement in gynecological cancer. J Epidemiol Biosta 2001; 6: 5-44.
10. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-1143.
11. Yessaian A, Magistris A, Burger RA, Monk BJ: Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy. Gynecol Oncol 2004; 94: 61-66.
12. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ: A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73: 177-183.
13. Ayhan A, Al RA, Baykal C, Demirtas E, Yuce K: Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer 2004; 14: 286-292.
14. Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF, Jr: Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997; 66: 31-35.
15. Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, et al: Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer. Gynecol Oncol 2004; 93: 628-631.